Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-15

Clinical Trial Update: A Pilot Study of Pyridostigmine in Pompe Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 pilot study evaluating pyridostigmine for Pompe disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyridostigmine (pyridostigmine)

Snippet

Sponsor: University of Florida | Conditions: Pompe Disease | EARLY_Phase 1 | Status: TERMINATED